Advertisement

Topics

Neurolief Ltd. Company Profile

05:03 EST 23rd January 2019 | BioPortfolio

Neurolief develops proprietary digital health neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. The company’s devices either complement or provide an alternative to pharmaceutical therapies, which are often ineffective and are associated with potential short- and long-term adverse effects. Neurolief’s products are groundbreaking electronic head mounted devices designed to concurrently neuromodulate target major neural pathways in the head and thereby affect brain regions that are involved in control and modulation of pain and mood. These devices are intended to provide a highly effective, side-effects free treatment for the hundreds of millions of patients worldwide.


News Articles [1 Associated News Articles listed on BioPortfolio]

Neurolief’s Relivion™ Digital Therapeutics Brain Neuromodulation Technology Highlighted at 4th Annual International Headache Symposium in Israel

Positive Preliminary Clinical Study Results Revealed During IHSI 2019 Keynote Address Neurolief’s Relivion™ digital therapeutics wearable neuromodulation technology...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

This study will evaluate the clinical performance and safety of a self administered abortive treatment for migraine headache using combined occipital and supraorbital transcutaneous nerve ...

Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)

Safety and Feasibility of Combined Trigeminal and Occipital Transcutaneous Nerve Stimulation (CTO-TNS) in Major Depressive Disorder (MDD)

Companies [1 Associated Companies listed on BioPortfolio]

Neurolief Ltd.

Neurolief develops proprietary digital health neuromodulation technology to treat neurological and neuropsychiatric disorders such as migraine and depression. The company’s d...

More Information about "Neurolief Ltd." on BioPortfolio

We have published hundreds of Neurolief Ltd. news stories on BioPortfolio along with dozens of Neurolief Ltd. Clinical Trials and PubMed Articles about Neurolief Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neurolief Ltd. Companies in our database. You can also find out about relevant Neurolief Ltd. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Bipolar Disorders
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. Over half of Bipolar cases develops before the age of 25. Bipolar ...

Pain
Pain is defined by the International Association for the Study of Pain as “an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage”. Some illnesses can be excruci...


Corporate Database Quicklinks



Searches Linking to this Company Record